Chaoju Eye Care Holdings Ltd

Chaoju Eye Care Holdings Ltd maintains a strong liquidity position with a current ratio of 4.37, indicating the company can easily cover its short-term liabilities with its current assets. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The debt-to-equity ratio of 0.1 suggests a conservative capital structure with minimal leverage, which reduces financial risk but may also limit growth opportunities. In terms of profitability, the company's return on equity (ROE) of 7.63% and return on assets (ROA) of 6.08% are below the industry median for Healthcare Facilities & Services, indicating that the company is generating returns that are not as strong as its peers. The operating margin, calculated as operating income of 268.3 million CNY on revenue of 1.36 billion CNY, is 19.7%, which is in line with the industry average. The company's revenue is primarily concentrated in the domestic market, with no significant international exposure disclosed. The three operating segments—Consumer Ophthalmic Services, Basic Ophthalmic Services, and Sales of Equipment and Medical Consumables—each contribute to the company's revenue, but the breakdown of segment contributions is not provided in the available data. Looking ahead, the company's revenue is expected to grow, supported by the increasing demand for ophthalmic services in China. The company's free cash flow of 21.5 million CNY is modest, and capital expenditures of 226.8 million CNY indicate ongoing investment in infrastructure and equipment. The company's growth trajectory is expected to be driven by expansion in its core services and potential market share gains. The company faces moderate liquidity risk due to its negative net cash position after debt. The risk assessment indicates a low dilution potential, with no significant dilution expected in the near term. The company's conservative capital structure and strong liquidity position mitigate credit risk, but the negative net cash position introduces some uncertainty. Recent events, including the company's latest financial filings and analyst estimates, suggest a stable outlook. The mean price target of 3.90 CNY is consistent with the median and high price targets, indicating analyst consensus on the company's valuation. The last actual EPS of 0.27 CNY and revenue of 1.36 billion CNY support the company's current valuation.